Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

These medications for BPH have known risks and may have new side effects.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Certain drugs that block specific enzymes can help treat prostate diseases.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

JAK inhibitors offer new hope for treating severe alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The treatment was ineffective in humans.

Hair regrowth improved, but quality of life did not.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.